医学
慢性阻塞性肺病
狼牙棒
心肌梗塞
人口
内科学
危险系数
冲程(发动机)
疾病
队列
回顾性队列研究
队列研究
物理疗法
急诊医学
重症监护医学
环境卫生
经皮冠状动脉介入治疗
置信区间
机械工程
工程类
作者
Eunice E. Cho,Laura C. Maclagan,Anna Chu,Ruth Croxford,Don D. Sin,Jacob A. Udell,Douglas Lee,Peter C. Austin,Andrea S. Gershon
出处
期刊:Thorax
[BMJ]
日期:2025-03-03
卷期号:: thorax-220991
被引量:1
标识
DOI:10.1136/thorax-2023-220991
摘要
Background Little is known about the association between chronic obstructive pulmonary disease (COPD) and cardiovascular disease (CVD) in people with established CVD. Knowing if COPD is associated with a higher risk of cardiovascular events would guide appropriate secondary prevention. Objective To examine the risk of COPD on major adverse cardiac events (MACEs, acute myocardial infarction, stroke and cardiovascular death) in a complete real-world population of a large province, with known CVD. Methods We conducted a retrospective population cohort study using health administration, medication, laboratory, electronic medical record and other data from Ontario, Canada. All people with a history of CVD with and without physician-diagnosed COPD as of 2008 were followed until 2016 and cardiac risk factors, sociodemographic factors, comorbidities and other factors were compared. Sequential cause-specific hazard models adjusting for these factors determined the risk of MACE in people with COPD. Results Of 496 056 individuals with CVD in Ontario on 1 January 2008, 69 161 (13.9%) had COPD. MACE occurred more frequently among those with CVD (45.3 per 1000 person-years) and COPD compared with those with CVD alone (28.6 per 1000 person-years) (HR 1.24, 95% CI 1.21–1.26) after adjustment for cardiac risk factors, comorbidities, socioeconomic status and other factors. People with COPD were less likely to receive preventive CVD medications or see a cardiologist. Conclusion In a large, real-world population of people with established CVD, COPD was associated with a higher rate of cardiovascular events but a lower rate of preventive therapy. Strategies are needed to improve secondary CVD prevention in the COPD population.
科研通智能强力驱动
Strongly Powered by AbleSci AI